Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis

Trends in Molecular Medicine

Volumn 9, Issue 8, 2003, Pages 351-359

  De Nigris, Filomena ^a   Lerman, Amir ^b   Ignarro, Louis J ^f   Williams Ignarro, Sharon ^f   Sica, Vincenzo ^c   Baker, Andrew H ^d   Lerman, Lilach O ^b   Geng, Yong J ^e   Napoli, Claudio ^c  

^a UNIVERSITY OF SALERNO   (Italy)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; LIPOPROTEIN; OXIDIZING AGENT;

AEROBIC METABOLISM; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; CELL FUNCTION; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; GENE CONTROL; HEART INFARCTION; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; OXIDATION; OXIDATIVE STRESS; RESPIRATORY BURST; REVIEW;

EID: 0042927973     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(03)00139-4     Document Type: Review

References (96)

1. Best, P.J. et al. (1999) Apoptosis. Basic concepts and implications in coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 19, 14-22
2. de Nigris, F. et al. (2001) Oxidation-sensitive transcription factors and molecular mechanisms in the arterial wall. Antioxid. Redox Signal. 3, 1119-1130
3. Falk, E. et al. (1995) Coronary plaque disruption. Circulation 92, 657-671
4. Smith, S.C. Jr (1996) Risk-reduction therapy: the challenge to change. Presented at the 68th scientific sessions of the American Heart Association November 13, 1995, Anaheim, California. Circulation 93, 2205-2211
5. Fuster, V. et al. (1990) Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 82, II47-II59
6. Libby, P. (1995) Molecular bases of the acute coronary syndromes. Circulation 91, 2844-2850
7. Napoli, C. and Palinski, W. (2001) Maternal hypercholesterolemia during pregnancy influences the later devolopment of atherosclerosis: clinical and pathogenic implications. Eur. Heart J. 22, 4-9
8. Palinski, W. and Napoli, C. (2002) The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J. 16, 1348-1360
9. Tsimikas, S. and Witztum, J.L. (2002) Shifting the diagnosis and treatment of atherosclerosis to children and young adults: a new paradigm for the 21st century. J. Am. Coll. Cardiol. 40, 2122-2124
10. Lenfant, C. (2002) Report of the task force on research in pediatric cardiovascular disease. Circulation 106, 1037-1042
11. McGill, H.C. Jr and McMahan, C.A. (1998) Determinants of atherosclerosis in the young. Pathobiological determinants of atherosclerosis in youth (PDAY) research group. Am. J. Cardiol. 82, 30T-36T
12. Berenson, G.S. et al. (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The bogalusa heart study. N. Engl. J. Med. 338, 1650-1656
13. Napoli, C. et al. (1999) Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study. Lancet 354, 1234-1241
14. Napoli, C. et al. (1997) Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low-density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 100, 2680-2690
15. Napoli, C. et al. (2001) Multiple role of reactive oxygen species in the arterial wall. J. Cell. Biochem. 82, 674-682
16. Palinski, W. and Witztum, J.L. (2000) Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J. Intern. Med. 247, 371-380
17. Binder, C.J. et al. (2002) Innate and acquired immunity in atherogenesis. Nat. Med. 8, 1218-1226
18. Boullier, A. et al. (2001) Scavenger receptors, oxidized LDL, and atherosclerosis. Ann. N. Y. Acad. Sci. 947, 214-222
19. Salvayre, R. et al. (2002) Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta 1585, 213-221
20. Geng, Y.J. (2001) Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis. Curr. Atheroscler Rep. 3, 234-242
21. Geng, Y.J. and Libby, P. (1995) Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1β-converting enzyme. Am. J. Pathol. 147, 251-266
22. Dimmeler, S. et al. (1996) Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett. 399, 71-74
23. Dimmeler, S. et al. (1997) Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation 95, 1760-1763
24. Sata, M. and Walsh, K. (1998) Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J. Clin. Invest. 102, 1682-1689
25. Escargueil-Blanc, I. et al. (1998) Apoptosis and activation of the sphingomyelin-ceramide pathway induced by oxidized low-density lipoproteins are not causally related in ECV-304 endothelial cells. J. Biol. Chem. 273, 27389-27395
26. Galle, J. et al. (1999) Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress. Kidney Int. 55, 1450-1461
27. Napoli, C. et al. (2000) Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J. 14, 1996-2007
28. de Nigris, F. et al. (2000) Modulation by α- and γ-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells. Biochem. Pharmacol. 59, 1477-1487
29. Johnson, T.M. et al. (1996) Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. U. S. A. 93, 11848-11852
30. Lopez-Candales, A. et al. (1996) Effects of ultraviolet light in vascular cells in vitro and in intact atherosclerotic explants: potential role of apoptosis in vascular biology. Biochem. Cell Biol. 74, 333-345
31. Langley, R.E. et al. (1997) Radiation-induced apoptosis in microvascular endothelial cells. Br. J. Cancer 75, 666-672
32. Napoli, C. et al. (2003) Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc. Natl. Acad. Sci. U. S. A. 100, 2112-2116
33. Dimmeler, S. et al. (1997) Angiotensin II induces apoptosis ofhuman endothelial cells. Protective effect of nitric oxide. Circ. Res. 81, 970-976
34. Dimmeler, S. et al. (1997) Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185, 601-607
35. Asai, K. et al. (2000) Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler. Thromb. Vasc. Biol. 20, 1493-1499
36. Hoffmann, J. et al. (2001) Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ. Res. 89, 709-715
37. de Boer, J. et al. (2002) Premature aging in mice deficient in DNA repair and transcription. Science 296, 1276-1279
38. Werlen, G. et al. (2003) Signaling life and death in the thymus: timing is everything. Science 299, 1859-1863
39. Pietenpol, J.A. and Stewart, Z.A. (2002) Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 181-182, 475-481
40. Dimmeler, S. et al. (1998) Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ. Res. 83, 334-341
41. Gimbrone, M.A. Jr et al. (1997) Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J. Clin. Invest. 100, S61-S65
42. Tricot, O. et al. (2000) Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 101, 2450-2453
43. Garcia-Cardena, G. et al. (2001) Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc. Natl. Acad. Sci. U. S. A. 98, 4478-4485
44. Noris, M. et al. (1995) Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ. Res. 76, 536-543
45. Dimmeler, S. et al. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605
46. de Nigris, F. et al. (2003) Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress. Proc. Natl. Acad. Sci. U. S. A. 100, 1420-1425
47. Ignarro, L.J. et al. (1999) Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol. 34, 879-886
48. Napoli, C. and Ignarro, L.J. (2001) Nitric oxide and atherosclerosis. Nitric Oxide 5, 88-97
49. Napoli, C. and Ignarro, L.J. (2003) Nitric oxide-releasing drugs. Annu. Rev. Pharmacol. Toxicol. 43, 97-123
50. Asmis, R. and Begley, J.G. (2003) Oxidized LDL promotes peroxide-mediated mitochondroal dysfunction and cell death in human macrophages: a caspase-3-independent pathway. Circ. Res. 92, e20-e29
51. Boulanger, C.M. et al. (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104, 2649-2652
52. Mallat, Z. et al. (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101, 841-843
53. Fournet-Bourguignon, M.P. et al. (2000) Phenotypic and functional changes in regenerated porcine coronary endothelial cells: increased uptake of modified LDL and reduced production of NO. Circ. Res. 86, 854-861
54. Walter, D.H. et al. (2002) Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105, 3017-3024
55. Vasa, M. et al. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89, E1-E7
56. Ito, H. et al. (1999) Endothelial progenitor cells as putative targets for angiostatin. Cancer Res. 59, 5875-5877
57. Irani, K. (2000) Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87, 179-183
58. Hsieh, C.C. et al. (2001) Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc. Res. 49, 135-145
59. Li, W. et al. (1998) OxLDL-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron. Free Radic. Res. 29, 389-398
60. Rosenblat, M. and Aviram, M. (1998) Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies. Free Radic. Biol. Med. 24, 305-317
61. Heermeier, K. et al. (1999) Oxidative stress mediates apoptosis induced by oxidized low-density lipoprotein and oxidized lipoprotein(a). Kidney Int. 56, 1310-1312
62. Napoli, C. et al. (1997) Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery in rabbits. Stroke 28, 2266-2271
63. Siow, R.C. et al. (1999) Induction of antioxidant stress proteins in vascular endothelial and smooth muscle cells: protective action of vitamin C against atherogenic lipoproteins. Free Radic. Res. 31, 309-318
64. Lizard, G. et al. (1998) Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J. 12, 1651-1663
65. Li, P.F. et al. (1997) Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 96, 3602-3609
66. de Nigris, F. et al. (2000) Evidence for oxidative activation of c-myc-dependent nuclear signaling in human coronary smooth muscle cells and in early lesions of watanabe heritable hyperlipidemic rabbits: protective effects of vitamin E. Circulation 102, 2111-2117
67. de Nigris, F. et al. (2001) c-Myc activation in early coronary lesions in experimental hypercholesterolemia. Biochem. Biophys. Res. Commun. 281, 945-950
68. Evan, G. and Littlewood, T. (1998) A matter of life and cell death. Science 281, 1317-1322
69. Napoli, C. et al, (2002) c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases? Neoplasia 4, 185-190
70. Bennett, M.R. et al. (1994) Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-γ, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ. Res. 74, 525-536
71. Neuzil, J. et al. (2002) Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and anti-atherogenic activity. Apoptosis 7, 179-187
72. Pike, A.C. et al. (1999) Structure of human factor VIIa and its implications for the triggering of blood coagulation. Proc. Natl. Acad. Sci. U. S. A. 96, 8925-8930
73. Badimon, J.J. et al. (1999) Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 99, 1780-1787
74. Bach, R. and Rifkin, D.B. (1990) Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc. Natl. Acad. Sci. U. S. A. 87, 6995-6999
75. Mallat, Z. et al. (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99, 348-353
76. van der Wal, A.C. et al. (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89, 36-44
77. Kolodgie, F.D. et al. (2000) Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am. J. Pathol. 157, 1259-1268
78. Bauriedel, G. et al. (1999) Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc. Res. 41, 480-488
79. Farb, A. et al. (1996) Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 93, 1354-1363
80. Burke, A.P. et al. (1997) Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N. Engl. J. Med. 336, 1276-1282
81. Schaub, F.J. et al. (2000) Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat. Med. 6, 790-796
82. Pollman, M.J. et al. (1998) Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat. Med. 4, 222-227
83. Palinski, W. and Napoli, C. (2002) Unraveling pleiotropic effects of statins on plaque rupture. Arterioscler. Thromb. Vasc. Biol. 22, 1745-1750
84. Bortner, C.D. and Cidlowski, J.A. (2002) Cellular mechanisms for the repression of apoptosis. Annu. Rev. Pharmacol. Toxicol. 42, 259-281
85. Hermanson, O. et al. (2002) Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol. Metab. 13, 55-60
86. de Nigris, F. et al. (2002) New insights in the transcriptional activity and coregulator molecules in the arterial wall. Int. J. Cardiol. 86, 153-168
87. Belanger, A.J. et al. (2001) Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: therapeutic implications of fratricidal mode of action. Cardiovasc. Res. 51, 749-761
88. Luo, Z. et al. (2001) Enhancement of Fas ligand-induced inhibition of neointimal formation in rabbit femoral and iliac arteries by coexpression of p35. Hum. Gene Ther. 12, 2191-2202
89. Chapman, J.G. et al. (2002) A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury. Eur. J. Pharmacol. 456, 59-68
90. Guttenplan, N. et al. (2001) Inhibition of myocardial apoptosis as a therapeutic target in cardiovascular disease prevention: focus on caspase inhibition. Heart Dis. 3, 313-318
91. Linnik, M.D. et al. (1995) Expression of Bcl-2 from a defective herpes-simplex virus-1 vector limits neuronal death in focal cerebralischemia. Stroke 26, 1670-1674
92. Sata, M. et al. (1998) Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc. Natl. Acad. Sci. U. S. A. 95, 1213-1217
93. George, S.J. et al. (2000) Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation 101, 296-304
94. Qi, J. et al. (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 9, 407-415
95. Fabunmi, R.P. et al. (1998) Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells - a potential protective mechanism in plaque stability. Circ. Res. 83, 270-278
96. Hasdai, D. et al. (1999) Coronary artery apoptosis in experimental hypercholesterolemia. Atherosclerosis 142, 317-325